2026
Development and validation of the Pressure Injury after Hospital Admission (PIAHA) screening tool for early assessment of hospital-acquired pressure injuries: a multiphase multicentre study protocol in acute care settings
BAHRAMNEZHAD, Fatemeh; Sebastian PROBST; Ali MORADI; Keivan GOHARI-MOGHADAM; Farshid RAHIMI-BASHAR et al.Základní údaje
Originální název
Development and validation of the Pressure Injury after Hospital Admission (PIAHA) screening tool for early assessment of hospital-acquired pressure injuries: a multiphase multicentre study protocol in acute care settings
Autoři
BAHRAMNEZHAD, Fatemeh; Sebastian PROBST; Ali MORADI; Keivan GOHARI-MOGHADAM; Farshid RAHIMI-BASHAR; Ata MAHMOODPOOR; Ali Akbar GHAMARI; Iman JAFARI; Amir VAHEDIAN-AZIMI a Andrea POKORNÁ
Vydání
BMJ Open, London, BMJ PUBLISHING GROUP, 2026, 2044-6055
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30307 Nursing
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.300 v roce 2024
Označené pro přenos do RIV
Ano
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
Wounds and Injuries; Hospitals; Preventive Health Services
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 4. 6. 2026 12:00, Mgr. Tereza Miškechová
Anotace
V originále
Introduction Early prediction of hospital-acquired pressure injuries (HAPIs) is crucial for delivering prompt therapeutic interventions and personalised preventive measures to hospitalised patients. However, existing pressure injury (PI) assessment tools often lack transparency, objectivity, comprehensiveness and reliability. This study protocol aims to identify risk factors, develop a screening tool (Pressure Injury after Hospital Admission - PIAHA), and conduct a two-step validation for the early prediction of PI after hospital admission.Methods and analysis This multiphase, multicentre, sequential research design comprises five phases. The first phase involves an umbrella review to synthesise comprehensive information on PI risk factors in hospitalised patients from published review studies. The second phase will use conventional content analysis and qualitative interviews with national and international experts to identify context-specific predictors of HAPIs. The third phase will employ a three-round E-Delphi method to integrate findings and establish a structured list of potential predictors. In the fourth phase, a cross-sectional study will evaluate the predictive value of identified risk factors for HAPI development among hospitalised patients, contributing to the development of the PIAHA screening tool. The final phase consists of a two-step validation: (1) a cross-sectional comparison of the PIAHA tool against the gold standard and (2) a cluster randomised controlled trial to compare the effectiveness and cost-effectiveness of the novel 'IDEAL SKIIN CARES' prevention bundle, administered by trained wound specialist nurses, vs routine standard care.Ethics and dissemination Ethical approval was granted by Baqiyatallah University of Medical Sciences (IR.BMSU.REC.1402.059) covering all study phases. Written informed consent will be obtained from participants or their legal representatives. The study follows the Declaration of Helsinki. Results will be disseminated via peer-reviewed publications, conferences, webinars, policy briefs and public engagement through social media, educational videos and podcasts.Implications for clinical practice The PIAHA tool promises to enhance early detection of HAPI risk, facilitating individualised prevention and optimising clinical resource allocation. Implementation of the IDEAL SKIIN CARES bundle may improve patient outcomes and reduce healthcare costs by standardising evidence-based preventive care.PROSPERO registration number CRD42024532133.Trial registration number NCT06369688.